LeMaitre Vascular (LMAT) Competitors

Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations, risk and community ranking.

Does the MarketBeat Community prefer STVN or LMAT?

LeMaitre Vascular received 484 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote.

Company	Underperform	Outperform
Stevanato Group	Outperform Votes 31 63.27%	Underperform Votes 18 36.73%
LeMaitre Vascular	Outperform Votes 515 70.45%	Underperform Votes 216 29.55%

Which has better valuation and earnings, STVN or LMAT?

Stevanato Group has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	$1.12B	6.12	$157.62M	$0.51	44.53
LeMaitre Vascular	$226.26M	7.90	$30.10M	$1.98	39.96

Which has more risk and volatility, STVN or LMAT?

Stevanato Group has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.

Do insiders and institutionals believe in STVN or LMAT?

84.6% of LeMaitre Vascular shares are held by institutional investors. 0.7% of Stevanato Group shares are held by insiders. Comparatively, 9.5% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Is STVN or LMAT more profitable?

LeMaitre Vascular has a net margin of 19.40% compared to Stevanato Group's net margin of 10.47%. LeMaitre Vascular's return on equity of 13.15% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	10.47%	9.86%	5.79%
LeMaitre Vascular	19.40%	13.15%	11.47%

Do analysts recommend STVN or LMAT?

LeMaitre Vascular has a consensus price target of $98.14, suggesting a potential upside of 24.04%. Given LeMaitre Vascular's higher probable upside, analysts plainly believe LeMaitre Vascular is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.63

Does the media refer more to STVN or LMAT?

In the previous week, LeMaitre Vascular had 1 more articles in the media than Stevanato Group. MarketBeat recorded 8 mentions for LeMaitre Vascular and 7 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.74 beat LeMaitre Vascular's score of 0.58 indicating that Stevanato Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
LeMaitre Vascular	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is STVN or LMAT a better dividend stock?

Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.3%. LeMaitre Vascular pays an annual dividend of $0.80 per share and has a dividend yield of 1.0%. Stevanato Group pays out 11.8% of its earnings in the form of a dividend. LeMaitre Vascular pays out 40.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Stevanato Group has increased its dividend for 1 consecutive years and LeMaitre Vascular has increased its dividend for 14 consecutive years. LeMaitre Vascular is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

LeMaitre Vascular beats Stevanato Group on 14 of the 21 factors compared between the two stocks.